lenvatinib plus pembrolizumab versus soc for previously treated metastatic colorectal cancer
Published 1 year ago • 185 plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
5:14
lenvatinib plus pembrolizumab after progression on immune checkpoint inhibitors for metastatic rcc
-
3:29
lenvatinib and pembrolizumab in microsatellite stable crc
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
0:52
dr. zamarin on lenvatinib plus pembrolizumab in endometrial cancer
-
9:02
bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
4:49
botensilimab plus balstilimab for metastatic heavily pretreated mss colorectal cancer
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
5:19
lenvatinib remains standard of care for first-line therapy in advanced hepatocellular carcinoma
-
4:03
real-world outcomes of patients with hcc treated with lenvatinib vs. atezolizumab plus bevacizumab
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
-
5:04
beacon: encorafenib plus cetuximab with or without binimetinib for braf v600e–mutant metastatic ...
-
7:05
health-related quality of life with lenvatinib plus pembrolizumab for patients with advanced rcc
-
1:39
micall2 upregulation promotes colorectal cancer via the wnt/β-catenin signaling pathway
-
3:06
jeff evans, asco 2018 – lenvatinib plus pembrolizumab in hepatocellular carcinoma